Cilo Cybin Holdings Company Description
Cilo Cybin Holdings Limited manufactures and sells medical cannabis products in South Africa, Australia, and internationally.
The company offers active pharmaceutical ingredients (API) products comprising tetrahydrocannabinol (THC) crude oils, THC distillates, and refined THCs; cannabidiol (CBD) isolate powders, CBD crystal resistant distillates (CRD), CBD crudes, CBD distillates, and CBD-V isolates; and minor cannabinoid products, such as CBN isolates, cannabigerol (CBG) isolates, CBG CRD, CBC isolates, THCV resins, and botanical CBT distillates.
It also provides contract manufacturing services for finished cannabinoid products, including oils and tinctures; vape formats; edibles; topicals, including creams, balms, lotions, and other formats; capsules; and secondary packaging, such as labels and batches.
In addition, the company operates an online shop for its products. Further, it invests in the biotech, biohacking, and pharmaceutical businesses.
Cilo Cybin Holdings Limited was founded in 2018 and is based in Centurion, South Africa.
| Country | South Africa |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Gabriel Theron |
Contact Details
Address: The Point Office Park Centurion, 0157 South Africa | |
| Phone | 27 861 420 421 |
| Website | cilocybin.com |
Stock Details
| Ticker Symbol | CCC |
| Exchange | Johannesburg Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | ZAR |
| ISIN Number | ZAE000310397 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Gabriel Christiaan Theron | Founder, Chief Executive Officer and Executive Director |
| Jessica Moodley-Theron | Acting Chief Financial Officer and Financial Director and Executive Director |
| Rouxne Styger | Company Secretary |
| Sascha Ramirez-Victor | Company Secretary |